A Multicenter Cohort Study Investigating the Consequences of Delayed Trastuzumab Treatment on Clinical Outcomes in Patients with HER2-Positive Early Breast Cancer
Phase of Trial: Phase IV
Latest Information Update: 11 Oct 2017
At a glance
- Drugs Trastuzumab (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- 11 Oct 2017 New trial record
- 12 Sep 2017 According to results presented at the 42nd European Society for Medical Oncology Congress, enrollment completion date for this study was 30 Jun 2012.
- 12 Sep 2017 Results presented at the 42nd European Society for Medical Oncology Congress.